戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 r suppressors in a mouse model of metastatic follicular thyroid cancer.
2 ncer and distant metastasis similar to human follicular thyroid cancer.
3  extent of surgery was seen in patients with follicular thyroid cancer.
4 6.8%) were malignant, and none of these were follicular thyroid cancers.
5 ted thyroid carcinomas include papillary and follicular thyroid cancers.
6 iant of papillary thyroid cancer (24.1%) and follicular thyroid cancer (1.4%) (P < 0.0001).
7 7%), occurring frequently in PHTS-associated follicular thyroid cancer (100%) and benign follicular n
8  thyroid cancer (23 of 39 patients; 59%) and follicular thyroid cancers (7 of 15 patients; 47%).
9 4% of histologically benign adenomas, 46% of follicular thyroid cancers, 71% of papillary thyroid can
10  mortality among patients with papillary and follicular thyroid cancer after postoperative iodine-131
11 nosis, no specific recommendations exist for follicular thyroid cancer and Hurthle cell carcinoma in
12 ents identify genetic subgroups of low-stage follicular thyroid cancer and provide evidence that foll
13 esmoplasia and inflammation in papillary and follicular thyroid cancers and the presence of multipote
14 nventional papillary thyroid cancer, 73 with follicular thyroid cancer, and 29 with the follicular va
15 comprised mainly of benign thyroid adenomas, follicular thyroid cancers, and papillary thyroid cancer
16  promoted cell proliferation and invasion of follicular thyroid cancer cell line, FTC-133 cells.
17 odide uptake in RAI-refractory papillary and follicular thyroid cancer cell lines.
18 thyroid epithelial cells or in papillary and follicular thyroid cancer cells.
19   The inability to distinguish microinvasive follicular thyroid cancer from benign follicular tumors
20 isoform-specific in vivo data are limited in follicular thyroid cancer (FTC), a PI3 kinase-driven tum
21 s of 17p13, including 10 medulloblastoma, 14 follicular thyroid cancer (FTC), and 9 ovarian cancer sp
22  that is, papillary thyroid cancer (PTC) and follicular thyroid cancer (FTC), the American Thyroid As
23 G/T at rs17849071 was found in patients with follicular thyroid cancer (FTC).
24     After radioiodine therapy, patients with follicular thyroid cancer had improvement in overall mor
25 red, but not sufficient to induce metastatic follicular thyroid cancer in Thrb(PV/PV) mice.
26                                              Follicular thyroid cancer is the second most common diff
27 d for papillary thyroid cancer (n = 341) and follicular thyroid cancer (n = 25) patients, sex, length
28            Despite certain unique aspects of follicular thyroid cancer presentation and prognosis, no
29 in vivo, PTEN is a critical regulator in the follicular thyroid cancer progression and invasiveness.
30  we comprehensively review the literature on follicular thyroid cancer to provide an evidence-based g
31  4 of 9 (44%) benign adenomas, 9 of 12 (75%) follicular thyroid cancers tumors, and 6 of 30 (20%) of